Founded in Germany in 1885, the top ten brands of cough medicine started with the production of tartaric acid, lactic acid and other chemical products, and is an innovative enterprise dedicated to R&D, production and marketing of drugs
Boehringer Ingelheim is currently the world's largest and most successful privately owned pharmaceutical group. Since its founding in 1885, family-owned Boehringer Ingelheim has been developing, manufacturing and marketing innovative medicines. Our main businesses include prescription drugs, consumer self-directed health drugs, biopharmaceuticals and animal health. After 100 years of development, Boehringer Ingelheim's footprint has extended from the banks of the Rhine River in Germany to more than 40 countries and regions around the world, and has successfully ranked among the top 20 pharmaceutical companies in the world.
Globally
In 1885, Albert. Mr. Boehringer founded Boehringer Ingelheim in Ingelheim, near Frankfurt, Germany.
For more than 100 years, research and development have driven the company's growth. From the initial production of tartaric acid, lactic acid and other chemical products, to the launch of many well-known drugs today, Boehringer Ingelheim's huge investment in research and development has enabled it to have excellent products in the fields of respiratory, cardiovascular, central nervous system, gastrointestinal tract, etc., so as to win a favorable market position; At the same time, Boehringer Ingelheim's scientists have won several academic awards, including the Nobel Prize. So far, the company has set up 7 R&D centers in Germany, Italy, Austria, the United States, Canada, Argentina and Japan and invested heavily in the research and development of new products.
In China
In March 1994, Boehringer Ingelheim entered China as an office, opening a chapter in China's development. In May 1995, Boehringer Ingelheim International Trade (Shanghai) Co., Ltd. was incorporated. At the beginning of 1998, Shanghai Boehringer Ingelheim Pharmaceutical Co., Ltd. was established in Zhangjiang "Medicine Valley", Shanghai, with an investment of 29 million US dollars, marking Boehringer's determination to take root in China. The modern factory in Zhangjiang has introduced the world's most advanced pharmaceutical equipment, and the design and management standards can be comparable to that of Boehringer Ingelheim factories in any other country. The factory is produced in strict accordance with international GMP standards.
Boehringer Ingelheim's main business in China includes prescription drugs, consumer health pharmaceuticals and animal health. The business scope covers all major provinces, cities and regions across the country. The company continues to bring its excellent products to the Chinese market, and the listed products cover respiratory, cardiovascular, central nervous system, anti-AIDS and other important fields, and have won wide reputation and recognition in the industry and market.
Health care business
With the increasing awareness of self-care, consumer self-care drugs for maintaining and improving health, preventing diseases, and treating minor illnesses such as colds and coughs are becoming more and more important. Boehringer Ingelheim's Autonomous Health Pharmaceuticals Division develops, manufactures and sells over-the-counter drugs and health foods. In 2005, its sales ranked 8th among the world's OTC drug manufacturers, and its product lines mainly cover four categories: physical and mental health, cold and cough, antipyretic and analgesic and vascular health care, and many brands are among the best in the world in their respective fields. For example, Mu Shutan and Biyuping occupy the first and second positions in the expectorant market, respectively; The Pharmaton range of products ranks second among vitamin and mineral supplements; Dulcolax ranks first in the ejector market.
As one of Boehringer Ingelheim's core businesses, we are committed to providing consumers in China with the highest quality self-health medicines. Musultan ® tablets and oral solutions have entered the over-the-counter drug list, and it is the No. 1 brand in China's expectorant and cough market. It can effectively regulate the serous and mucus secretion of the airway, activate the ciliated mucus transport system, and can play the normal protective function of surfactant, so the clearing effect penetrates deep into the alveoli, and is known as the "whole lung dynamic expectorant", and is also known as the "respiratory scavenger". The efficacy of Musultan is remarkable and is well received by the majority of patients, and the oral solution is preferred by children and parents because of its delicious fruit taste.
